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F o r P e e r R e v i e w Diagnosis of testicular carcinoma in situ, (intratubular-and micro-invasive) seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections. TGCTs are rare in the general population, with an incidence between 6 and 11 per 100.000 in Caucasian males, they represent the most common cancer in men aged between 15 and 45 years and the incidence is still rising [2] . High success rates in clinical management of TGCTs have been achieved using a combination of surgery, irradiation and chemotherapy [3] . In fact, standard care for therapy for TGCTs is radical orchiectomy, which may be combined with irradiation and/or cisplatin-based chemotherapy, depending on the histology of the tumor, as well as the disease stage. In the diagnostic work up, the presence of elevated serum markers α-foetoprotein (AFP), β-human chorion gonadotropin (β-HCG) and/or lactate dehydrogenase (LDH) is informative. However, in present clinical practice a tumor in a testis is in itself enough reason to perform a radical orchiectomy, without a histological diagnosis of the testicular lesion. Recently, more attention is given to the possibility of testis sparing surgery in specific patients. This alternative procedure may be of interest for patients with a bilateral TGCT or an affected monotestis, in whom standard care would result in complete castration and life long dependence on hormone substitution (testosterone replacement) [4] . To avoid these sequelae, organ sparing surgery might be an option, in which the tumor is enucleated and the normal appearing testis parenchyma is preserved [5, 6] . Other patients that may benefit from such an approach are those without elevated serum markers and a small, possibly benign tumor [7] . However, a limitation is that no distinction can be made between a benign and a malignant lesion using the available imaging techniques, like ultrasonography or magnetic resonance imaging. Therefore, by definition, exploratory surgery is required and frozen section analysis of tumor tissue. In fact, histological investigation should be done of the lesion and its adjacent parenchyma. Carcinoma In Situ (CIS), also known as Intratubular Germ Cell Neoplasia Unclassified (IGCNU) [8] , or Testicular Intratubular Neoplasia (TIN), is the precursor of all TGCTs [9] . Identification of CIS is sufficient for the diagnosis of a TGCT, which is by definition malignant. CIS is present in the majority of patients with an invasive TGCT, more frequently in patients with nonseminomas than with seminomas, which is likely related to the immune response [10] . It is reported that 70% of the patients with CIS will develop an invasive tumor within 7 years, which is extrapolated to 100% at 10 years [11] . Of importance is the fact that CIS can be effectively treated by local low dose irradiation with preservation of hormonal function of the testis in most cases [11] . In daily practice, CIS is diagnosed using (formalin-, Stieve's-or Bouin-) fixed, paraffin-embedded tissue, preferably supported by immunohistochemical staining, for example OCT3/4 [12] [13] [14] [15] , or c-KIT (CD117) and PLAP [8] . Phosphatse (PLAP and GCAP) [16] . No specific antibodies against all these various isozymes are currently available. Alkaline phosphatase is present in migrating primordial germ cells (PGCs), and in gonocytes as well as in prespermatogonia in embryonal gonads [17] . In fact, this enzymatic activity was initially used to identify mouse PGCs during normal embryogenesis [18, 19] . In normal testis parenchyma of the adolescents and adults, no endogeneous activity of alkaline phosphatase is present, except in the endothelial cells of small blood vessels [20] . It is known that PLAP and GCAP is abundantly expressed in seminoma and embryonal carcinoma F o r P e e r R e v i e w 5 [21, 22] . Since the enzyme is also present in CIS, it may be applied as a marker for the early diagnosis of TGCTs [17] .
Here we present the application of a direct histochemical detection of alkaline phosphatase enzyme reactivity, which detects the activity of all enzymes, to 
MATERIALS AND METHODS
Use of tissues for scientific purposes as included in this study was approved by an institutional review board (MEC 02.981 and CCR2041), and the samples were used according to the "Code for Proper Secondary Use" (FMWV) (version 2002).
Primary tissue handling:
The material used was handled by routine procedures. Upon incision of the specimen, a digital image was generated, and possibly heterogeneity of the specimen identified. Representative parts of the tumor area(s) (possible including different elements) and adjacent parenchyma were cut and fixed in 10% buffered formalin for maximum 24 hours, and subsequently embedded in paraffin. Parallel areas of both the tumor and parenchyma were cut and snap frozen in liquid nitrogen.
This according to special requirements. Small fresh biopsies need to be prepared as fast as possible after surgical intervention. The biopsies were placed on a small piece of thin cork, covered with a small piece of wet filter paper, after which they were directly frozen in liquid nitrogen. Larger pieces of testis tissue were snap frozen, without the cork support, again in liquid nitrogen. In addition, special care has to be taken in cutting the sections: under no circumstances should the frozen tissue be thawed, which will compromise morphology and enzyme-histochemical staining, and thus the interpretation of the slides.
The snap frozen samples were investigated for histology using Subsequently they were covered with an aqueous mounting medium (Imsol-mount;
Klinipath; 4059), and visually inspected, after which they could be stored in the archive. 
DISCUSSION
Individualized treatment of cancer patients is becoming a major issue in current clinical practice. This is aimed at achieving optimal treatment success rates and at the same time reduction of treatment side effects, to ensure quality of life, both at short and long term. Although intra-operative frozen section examination is commonly applied in surgical management for various malignancies, its role in clinical management of testicular masses is still in its infancy. However, organ preserving surgery can be the preferred therapeutic intervention in some cases.
These may include patients with a benign testicular lesion, as demonstrated by for example Heidenreich and coworkers in a series of 18 patients treated with enucleation of a benign tumor and analysis of frozen biopsies of the adjacent parenchyma [25] . In addition, an adenomatoid tumor of the testis was treated by testis sparing surgery after it was diagnosed as benign by intra-operative frozen section examination [26] . Moreover, a segmental testicular infarction, simulating a TGCT, was treated by partial orchiectomy after a frozen section diagnoses. [27] .
Currently, standard treatment of a primary TGCT is radical orchiectomy, followed by additional treatment depending on the stage of the disease and characteristics of the tumor, being either irradiation or chemotherapy [3] . However, some patients might benefit from a more conservative surgical approach. This might prevent complete castration in case of patients with a tumor in a solitary testis, a bilateral testicular tumor, or a second testicular tumor after an initial unilateral orchiectomy. In fact, organ preserving surgery is not yet standard care in these patients [28, 29] . Furthermore, sufficient endocrine function of the remaining testicular parenchyma should remain after the operation. If organ preserving surgery is to be performed, detailed investigation of the adjacent testicular parenchyma is required to determine the presence of CIS, as well as (intratubular-and microinvasive) seminoma and embryonal carcinoma. The other histological elements are more easy to diagnose based on standard histological analysis. If CIS is histologically documented, adjuvant radiotherapy of the remaining testicular tissue is strongly recommended according to the management strategy for CIS in unilateral tumors [7] . If invasive tumor components are identified, orchiectomy must be considered. Histological examination is predominantly performed on fixed tissue, which benefits from optimally preserved morphology. This is significantly reduced using snap frozen tissue. discrepancies were found between the diagnoses made using the two methods. In addition, the test can be easily implemented in routine clinical histopathology.
In conclusion, the dAP test we introduce is a valuable diagnostic tool in testis conserving surgery, allowing direct evaluation of the presence of CIS, seminoma or embryonal carcinoma. With the availability of this intra-operative test the development and implementation of testis sparing surgery is more feasible than thus far. Even so testis sparing surgery should be performed at a centre with sufficient experience in the management of this rare clinical situation [30] . However, some limitations must be kept in mind. Although CIS is found in most affected testicular parenchyma samples in case of a type II GCT, is can show a heterogeneous pattern.
This patchy distribution can result in a false negative finding upon biopsy analysis, which is not influenced by either detection technique applied [16] . In this context it is of relevance that two independent surgical biopsies are recommended for detection of CIS in a normal-sized testis, each with a diameter of at least 3 mm [31] . However, although the risk will be small, the presence can never be absolutely excluded in case of a negative finding on biopsy material. Therefore proper size of the biopsy and subsequent handling and analysis are of great importance for optimal diagnosis. 
